Published in Immunology on May 01, 1994
On the cell biology of pit cells, the liver-specific NK cells. World J Gastroenterol (2000) 0.86
IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol (1990) 2.15
Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J Immunol (1992) 1.96
Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol (1990) 1.74
Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med (1991) 1.51
The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol (1990) 1.30
Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology (1992) 1.09
Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology (1991) 1.04
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology (1992) 0.95
Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol (1991) 0.93
CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activation. J Immunol (1991) 0.91
Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology (1993) 0.89
Liver sinusoidal cytotoxic cells are recruited from blood and divide locally. J Hepatol (1991) 0.86
Characterization of liver-associated natural killer cells in patients with liver tumors. Hepatology (1991) 0.85
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J (1998) 10.01
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology (2001) 2.73
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology (2001) 2.41
Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology (1999) 1.94
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene (2006) 1.84
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology (2001) 1.68
Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 10 adult French patients. Hum Pathol (1995) 1.51
[Lichen planus in children: role of the campaign for hepatitis B vaccination]. Ann Dermatol Venereol (1998) 1.48
Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes. Nature (1989) 1.46
Morphologic structure of bile canaliculi after bile duct ligation in the rat. A time-course study. Arch Pathol Lab Med (1982) 1.45
Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer (2000) 1.44
A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene (1999) 1.43
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
[Benign liver cell tumors: recent results, from molecular biology to diagnosis]. Gastroenterol Clin Biol (2008) 1.37
Idiopathic eruptive macular pigmentation: report of five patients. Pediatr Dermatol (1996) 1.35
Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut (2005) 1.34
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol (2001) 1.32
Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol (2000) 1.31
Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy (2006) 1.24
Asymmetric periflexural exanthem of childhood: a clinical, pathologic, and epidemiologic prospective study. Arch Dermatol (1999) 1.23
Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg (2000) 1.22
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene (1999) 1.22
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol (2000) 1.21
T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J Immunol (1986) 1.19
Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney Int (2007) 1.18
Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol (1999) 1.17
Nerves and perisinusoidal cells in human liver. J Hepatol (1990) 1.17
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med (2004) 1.13
Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology (1997) 1.12
Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol (1999) 1.10
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut (2004) 1.10
Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med (1992) 1.09
Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res (1997) 1.07
Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol (2001) 1.04
Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res (2001) 0.99
[Mechanisms of hepatic fibrogenesis]. Arch Pediatr (2002) 0.98
Idiopathic aseptic facial granuloma (pyodermite froide du visage): a pediatric entity? Arch Dermatol (2001) 0.97
Hepatoportal sclerosis. Semin Liver Dis (1995) 0.96
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype. Aliment Pharmacol Ther (2007) 0.95
Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene (2001) 0.95
Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun (1999) 0.94
Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest (1999) 0.93
Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study. Hepatology (1995) 0.93
Morphologic investigation of sinusoidal cells. Semin Liver Dis (1993) 0.91
Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease. Am J Pathol (1995) 0.91
Giant vertebral notochordal rest: a new entity distinct from chordoma. Histopathology (2005) 0.91
Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma. Mod Pathol (1997) 0.90
Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut (2007) 0.90
[Semi-automated quantitative method for detecting the loss of heterozygosity at the long arm of chromosome 4 in hepatocellular carcinoma]. Gastroenterol Clin Biol (1999) 0.90
Longitudinal melanonychia in children. A study of eight cases. Arch Dermatol (1996) 0.90
Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. World J Gastroenterol (2005) 0.90
Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytes. Exp Cell Res (1996) 0.90
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS (1990) 0.89
Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest (2000) 0.89
Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transpl Int (1996) 0.89
Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol (1999) 0.89
Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology (1993) 0.89
Fine structure of hepatic sinusoids and sinusoidal cells in disease. J Electron Microsc Tech (1990) 0.88
Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. J Med Virol (2002) 0.88
Expression of hepatocyte growth factor in human hepatocellular carcinoma. J Hepatol (2001) 0.88
Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities. Gastroenterology (1987) 0.87
Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol (1995) 0.87
Interleukin 2 up-regulates its own production. J Immunol (1987) 0.87
Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. Lab Invest (1997) 0.87
Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend (2011) 0.87